Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$4.75 - $12.41 $1.8 Million - $4.69 Million
-378,245 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$8.73 - $12.95 $2.49 Million - $3.69 Million
285,041 Added 305.82%
378,245 $4.12 Million
Q3 2019

Nov 13, 2019

SELL
$14.16 - $25.34 $662,631 - $1.19 Million
-46,796 Reduced 33.43%
93,204 $1.37 Million
Q2 2019

Aug 13, 2019

BUY
$27.0 - $30.25 $3.78 Million - $4.24 Million
140,000 New
140,000 $3.8 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $165M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.